Photo by impulsq from unsplash
Women with hereditary mutation in breast cancer‐associated genes (BRCA1−/2−) have a higher lifetime risk of developing ovarian cancer. Here, we aimed to investigate the effect of mifepristone, a selective progesterone… Click to show full abstract
Women with hereditary mutation in breast cancer‐associated genes (BRCA1−/2−) have a higher lifetime risk of developing ovarian cancer. Here, we aimed to investigate the effect of mifepristone, a selective progesterone receptor modulator of ovarian mesenchymal stem/stromal cells (MSC) from BRCA1−/2− carriers.
Keywords:
stem stromal;
stromal cells;
effect;
ovarian mesenchymal;
brca1 carriers;
mesenchymal stem
Journal Title: Acta Obstetricia et Gynecologica Scandinavica
Year Published: 2019
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Acta Obstetricia et Gynecologica Scandinavica
Year Published: 2019
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!